News | June 03, 2026
Alkem launches single-shot Semaglutide pre-filled syringes at Rs. 350
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The first Phase III and second Phase III trials will be multi-centre, randomised, assessor-blind, active-comparator studies to determine the efficacy, safety and tolerability of orally administered Zintrodiazine
Price of the starting dose of Ozempic and Wegovy reduced by 36% and 48% respectively
The announcement marks Dr. Reddy’s Day?1 entry into the GLP?1 receptor agonists therapy space and readiness to serve patients in India
Company to launch product after the expiry of semaglutide patent in India
This innovation enhances viral stability, preserves potency, and reduces allergic reactions and antigen crystallisation-related issues
Sodium Zirconium Cyclosilicate powder for oral suspension 5g (Lokelma) is indicated for the treatment of hyperkalaemia in adult patients
States exhorted to ensure rational use of cough syrups, particularly among children, as most coughs are self-limiting and do not require pharmacological treatment
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
